# Neurowyzr Pte

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neurowyzr-pte

- Industry: Software
- Headquarters: Singapore
- Website: www.neurowyzr.com
- Total disclosed funding: $5.4M
- Latest round: Seed (Aug 10, 2023)
- Investors on record: 5

## About

Based in Singapore, and founded in 2019, Neurowyzr Pte Ltd operates as a software company that offers a platform where users can access neuroscience partners to assess their brain health. In August 2023, Neurowyzr Pte Ltd. raised USD 5.39 million in seed funding from Peak XV Partners, Jungle Ventures, Apollo Hospitals Enterprise Ltd., HealthXCapital, and Surge. As of 2023, the company is led by its CEO Pang Sze Yunn

The company offers mental healthcare services such as a digital brain function screen that detects early brain decline using medical-grade brain games and helps to improve brain health and personal effectiveness. Its product profile also includes Attayn, which helps clients provide knowledge to their workers about cognitive capabilities, emotional intelligence, etc. The Nhyre offers tools that help companies identify the right candidate for roles A gamified brain test called Attycus maximizes staff productivity. It also offers Omni-platform care which helps users work with neurologists, psychologists, and allied health professionals on brain care.

The company plans to use the August 2023 funding to support product enhancement and business expansion.

## Funding rounds

- Seed, Aug 10, 2023, $5.4M — Apollo Hospitals Enterprise Ltd., Jungle Ventures, HealthXCapital, Surge, Peak XV Partners

## Investors

- Apollo Hospitals Enterprise Ltd. — Seed
- Jungle Ventures (https://capitalatlas.ai/funds/jungle-ventures) — Seed
- HealthXCapital (https://capitalatlas.ai/funds/healthxcapital) — Seed
- Surge (https://capitalatlas.ai/funds/surge) — Seed
- Peak XV Partners (https://capitalatlas.ai/funds/peak-xv-partners) — Seed